Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
Dublin, Aug. 04, 2025 (GLOBE NEWSWIRE) -- The "White Biotechnology Market - A Global and Regional Analysis: Focus on Application, Product, and Country Analysis - Analysis and Forecast, 2025-2034"...
-
Please read the full announcement in PDF. Attachments 2025_36_Major_Shareholders_Announcement Novozymes B 16 July 2025_Final ...
-
New York, USA, July 09, 2025 (GLOBE NEWSWIRE) -- Global Medical Device Cleaning Market is Expected to Showcase a Significant Growth at a CAGR of ~7% by 2032 | DelveInsight The medical device...
-
Biosolutions could create more than 600,000 jobs and unlock hundreds of billions in growth for Europe A new report reveals that biosolutions could generate EUR 133 billion in economic gains...
-
Novonesis has now completed the announced share buyback program of B shares worth up to EUR 100 million (DKK 746 million) in total during 2025. As of June 27th, 2025, Novonesis has purchased an...
-
Austin, June 26, 2025 (GLOBE NEWSWIRE) -- The Glucaric Acid Market Size was valued at USD 1,142.00 million in 2024 and is expected to reach USD 1,972.30 million by 2032, growing at a CAGR of 7.08%...
-
Luton, Bedfordshire, United Kingdom, June 24, 2025 (GLOBE NEWSWIRE) -- Agrochemicals and Pesticides Market Outlook (2024–2034): The Evolution of Modern Farming Inputs As the global population...
-
As of June 20th, 2025, Novonesis has purchased an accumulated 1,660,344 shares with a transaction value of DKK 713,0 million under the share buyback program announced by Novonesis in Company...
-
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital...
-
Pursuant to Section 30 of the Danish Capital Markets Act, Novonesis hereby announces that BlackRock, Inc. has notified Novonesis of the following status relating to the position of share capital...